Suraksha Diagnostic's Q4 FY 2025-26 Quarterly Results

Result Summary

• Suraksha Diagnostic Ltd reported a 5.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 24.7%.
• Its expenses for the quarter were up by 7.2% QoQ and 29.2% YoY.
• The net profit decreased 14.9% QoQ and decreased 14.1% YoY.
• The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 1.21 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Suraksha Diagnostic Ltd is a company operating in the healthcare diagnostics sector. The primary business of Suraksha Diagnostic Ltd revolves around providing diagnostic and pathology services. These services are crucial for medical professionals when diagnosing diseases and monitoring patient health. As of the latest available information, there are no specific recent major developments publicly available concerning Suraksha Diagnostic Ltd. The company operates in a competitive industry characterized by technological advancements and growing demand for healthcare services.

Revenue

In Q4FY26, Suraksha Diagnostic Ltd reported a total income of ₹82.20 crores. This represents a quarter-over-quarter (QoQ) increase of 5.0% compared to the previous quarter, Q3FY26, where the total income stood at ₹78.31 crores. Furthermore, on a year-over-year (YoY) basis, the total income increased by 24.7% from ₹65.91 crores in Q4FY25. This growth in revenue highlights the company's ability to generate increased income over both the short and long term, reflecting positive performance in its operations.

Profitability

For Q4FY26, Suraksha Diagnostic Ltd's profit before tax was ₹9.98 crores, slightly down by 0.8% from ₹10.06 crores in Q3FY26. On a year-over-year basis, this represents an increase of 8.4% from ₹9.21 crores in Q4FY25. The tax expense for the quarter was ₹3.82 crores, showing a significant increase of 35.5% QoQ and 87.3% YoY. Consequently, the profit after tax for Q4FY26 was ₹6.16 crores, which reflects a decline of 14.9% QoQ and 14.1% YoY. The earnings per share also followed a similar pattern, decreasing to ₹1.21 from ₹1.44 in the previous quarter and ₹1.42 in the same quarter of the previous year, indicating a reduction of 16.0% QoQ and 14.8% YoY.

Operating Metrics

The financial data for Suraksha Diagnostic Ltd reveals that total expenses in Q4FY26 amounted to ₹72.22 crores, which is a 7.2% increase from ₹67.39 crores in Q3FY26 and a 29.2% rise from ₹55.89 crores in Q4FY25. This increment in expenses is notable and has impacted the overall profitability metrics for the company. The trend of increasing expenses could be an area of focus in understanding the company's operational dynamics. No additional specific financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio are directly calculable from the provided data, thus further analysis would be required for these metrics.